Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR)–An analysis of UK's …
A Saha, M Beasley, N Hatton, P Dickinson… - Radiotherapy and …, 2021 - Elsevier
Abstract Background Stereotactic Ablative Radiotherapy (SABR) is the standard treatment
for early-stage medically inoperable lung cancer. Predictors of radiation pneumonitis (RP) in
patients treated with SABR are poorly defined. In this study, we investigate clinical and
dosimetric parameters, which can predict symptomatic RP in early-stage lung cancer
patients treated with SABR. Materials and methods Patients treated with lung SABR
between May 2009 and August 2018, in a single United Kingdom (UK) radiotherapy center …
for early-stage medically inoperable lung cancer. Predictors of radiation pneumonitis (RP) in
patients treated with SABR are poorly defined. In this study, we investigate clinical and
dosimetric parameters, which can predict symptomatic RP in early-stage lung cancer
patients treated with SABR. Materials and methods Patients treated with lung SABR
between May 2009 and August 2018, in a single United Kingdom (UK) radiotherapy center …